Login
Home
Charts
Search
Watchlist
Products

Star Health & Allied Insurance Company Ltd

STARHEALTH·NSE
549.20+0.84%Wed, 23 Sept '26

Star Health & Allied Insurance Company Ltd

STARHEALTH
NSE
549.20
+0.84%
|Wed, 23 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
32,327Cr
Close
Close Price
549.20
Industry
Industry
Finance - Non Life Insurance
PE
Price To Earnings
38.30
PS
Price To Sales
1.77
Revenue
Revenue
18,299Cr
Rev Gr TTM
Revenue Growth TTM
12.69%
PAT Gr TTM
PAT Growth TTM
-12.54%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
3,3573,4613,5773,6923,9144,0013,9874,3364,2664,4454,6714,917
Growth YoY
Revenue Growth YoY%
15.016.017.215.716.615.611.417.49.011.117.213.4
Expenses
ExpensesCr
3,2843,1803,4873,3803,8993,8494,0734,0494,2854,3754,1664,492
Operating Profit
Operating ProfitCr
732819031216153-87288-1969505425
OPM
OPM%
2.28.12.58.40.43.8-2.26.6-0.51.610.88.7
Other Income
Other IncomeCr
5934697685546956508611,1088068066851,258
Interest Expense
Interest ExpenseCr
000000000000
PBT
PBTCr
167388190426149287-158878173-60742
Tax
TaxCr
4298471073872-11502345-4192
PAT
PATCr
125290142319111215143855128-64550
Growth YoY
PAT Growth YoY%
34.637.639.810.8-11.2-25.7-99.637.4-50.7-40.4-12,586.325.5
NPM
NPM%
3.78.44.08.62.85.40.010.11.32.9-1.411.2
EPS
EPS
2.15.02.45.51.93.70.07.50.92.21.99.3
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
3,3573,4613,5773,6923,9144,0013,9874,3364,2664,4454,6714,917
Growth YoY
Revenue Growth YoY%
15.016.017.215.716.615.611.417.49.011.117.213.4
Expenses
ExpensesCr
3,2843,1803,4873,3803,8993,8494,0734,0494,2854,3754,1664,492
Operating Profit
Operating ProfitCr
732819031216153-87288-1969505425
OPM
OPM%
2.28.12.58.40.43.8-2.26.6-0.51.610.88.7
Other Income
Other IncomeCr
5934697685546956508611,1088068066851,258
Interest Expense
Interest ExpenseCr
000000000000
PBT
PBTCr
167388190426149287-158878173-60742
Tax
TaxCr
4298471073872-11502345-4192
PAT
PATCr
125290142319111215143855128-64550
Growth YoY
PAT Growth YoY%
34.637.639.810.8-11.2-25.7-99.637.4-50.7-40.4-12,586.325.5
NPM
NPM%
3.78.44.08.62.85.40.010.11.32.9-1.411.2
EPS
EPS
2.15.02.45.51.93.70.07.50.92.21.99.3

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
3,7144,8854,87710,28911,76313,58015,65917,38618,299
Growth
Revenue Growth%
31.6-0.2111.014.315.415.311.012.7
Expenses
ExpensesCr
4,5315,6277,76113,70913,11115,24417,74119,96817,319
Operating Profit
Operating ProfitCr
-818-741-2,884-3,421-1,348-1,664-2,082-2,582980
OPM
OPM%
-22.0-15.2-59.1-33.3-11.5-12.3-13.3-14.85.3
Other Income
Other IncomeCr
000002563,555
Interest Expense
Interest ExpenseCr
000000000
PBT
PBTCr
182413-1,446-1,3978261,129861754933
Tax
TaxCr
54145-360-356208284215197256
PAT
PATCr
128268-1,086-1,041619845646557669
Growth
PAT Growth%
109.0-505.14.2159.436.6-23.6-13.8-12.5
NPM
NPM%
3.55.5-22.3-10.15.36.24.13.23.7
EPS
EPS
0.30.6-21.8-18.610.714.511.09.514.3
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
3,7144,8854,87710,28911,76313,58015,65917,38618,299
Growth
Revenue Growth%
31.6-0.2111.014.315.415.311.012.7
Expenses
ExpensesCr
4,5315,6277,76113,70913,11115,24417,74119,96817,319
Operating Profit
Operating ProfitCr
-818-741-2,884-3,421-1,348-1,664-2,082-2,582980
OPM
OPM%
-22.0-15.2-59.1-33.3-11.5-12.3-13.3-14.85.3
Other Income
Other IncomeCr
000002563,555
Interest Expense
Interest ExpenseCr
000000000
PBT
PBTCr
182413-1,446-1,3978261,129861754933
Tax
TaxCr
54145-360-356208284215197256
PAT
PATCr
128268-1,086-1,041619845646557669
Growth
PAT Growth%
109.0-505.14.2159.436.6-23.6-13.8-12.5
NPM
NPM%
3.55.5-22.3-10.15.36.24.13.23.7
EPS
EPS
0.30.6-21.8-18.610.714.511.09.514.3

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Equity Capital
Equity CapitalCr
4564915485765825855885880
Reserves
ReservesCr
9371,1543,6725,8105,9936,0856,4716,9870
Borrowings
BorrowingsCr
2502502507204704704704700
Other Liabilities
Other LiabilitiesCr
3,2304,232-728-1,755-1,118-22553-240
Total Liabilities
Total LiabilitiesCr
4,8726,1273,7425,3515,9276,9157,5828,0210
Fixed Assets
Fixed AssetsCr
991171111753232870
Advances
AdvancesCr
7099771,2656838441,2991,6822,072
Cash Equivalents
Cash EquivalentsCr
8936111,8795643094456681,4440
Other Assets
Other AssetsCr
3,2704,5394993,9874,6624,9974,9094,2200
Total Assets
Total AssetsCr
4,8726,1273,7425,3515,9276,9157,5828,0210
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Equity Capital
Equity CapitalCr
4564915485765825855885880
Reserves
ReservesCr
9371,1543,6725,8105,9936,0856,4716,9870
Borrowings
BorrowingsCr
2502502507204704704704700
Other Liabilities
Other LiabilitiesCr
3,2304,232-728-1,755-1,118-22553-240
Total Liabilities
Total LiabilitiesCr
4,8726,1273,7425,3515,9276,9157,5828,0210
Fixed Assets
Fixed AssetsCr
991171111753232870
Advances
AdvancesCr
7099771,2656838441,2991,6822,072
Cash Equivalents
Cash EquivalentsCr
8936111,8795643094456681,4440
Other Assets
Other AssetsCr
3,2704,5394993,9874,6624,9974,9094,2200
Total Assets
Total AssetsCr
4,8726,1273,7425,3515,9276,9157,5828,0210

Cash Flow

Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
776647890561,2761,3101,3791,873
Investing Cash Flow
Investing Cash FlowCr
-731-1,006-2,418-3,786-1,097-1,177-1,151-1,067
Financing Cash Flow
Financing Cash FlowCr
3331222,6132,509-26823-4-31
Net Cash Flow
Net Cash FlowCr
379-2371,086-1,221-89156224775
Free Cash Flow
Free Cash FlowCr
746614844-71,2291,1871,2971,797
CFO To PAT
CFO To PAT%
605.5241.6-82.0-5.3206.3155.0213.4336.4
CFO To EBITDA
CFO To EBITDA%
-94.9-87.3-30.9-1.6-94.7-78.7-66.2-72.6
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
776647890561,2761,3101,3791,873
Investing Cash Flow
Investing Cash FlowCr
-731-1,006-2,418-3,786-1,097-1,177-1,151-1,067
Financing Cash Flow
Financing Cash FlowCr
3331222,6132,509-26823-4-31
Net Cash Flow
Net Cash FlowCr
379-2371,086-1,221-89156224775
Free Cash Flow
Free Cash FlowCr
746614844-71,2291,1871,2971,797
CFO To PAT
CFO To PAT%
605.5241.6-82.0-5.3206.3155.0213.4336.4
CFO To EBITDA
CFO To EBITDA%
-94.9-87.3-30.9-1.6-94.7-78.7-66.2-72.6

Ratios

Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
40,89930,16031,78720,94026,90532,327
Price To Earnings
Price To Earnings
48.837.632.448.338.3
Price To Sales
Price To Sales
3.92.52.31.31.51.8
Price To Book
Price To Book
8.85.55.03.03.54.3
EV To EBITDA
EV To EBITDA
-12.0-22.5-19.1-10.0-10.031.7
Profitability Ratios
Profitability Ratios
OPM
OPM%
-22.0-15.2-59.1-33.3-11.5-12.3-13.3-14.85.3
NPM
NPM%
3.55.5-22.3-10.15.36.24.13.23.7
ROCE
ROCE%
11.121.8-32.4-19.711.715.811.49.4
ROE
ROE%
9.216.3-25.7-16.39.412.79.27.3
ROA
ROA%
2.64.4-29.0-19.410.412.28.56.9
Solvency Ratios
Solvency Ratios
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
40,89930,16031,78720,94026,90532,327
Price To Earnings
Price To Earnings
48.837.632.448.338.3
Price To Sales
Price To Sales
3.92.52.31.31.51.8
Price To Book
Price To Book
8.85.55.03.03.54.3
EV To EBITDA
EV To EBITDA
-12.0-22.5-19.1-10.0-10.031.7
Profitability Ratios
Profitability Ratios
OPM
OPM%
-22.0-15.2-59.1-33.3-11.5-12.3-13.3-14.85.3
NPM
NPM%
3.55.5-22.3-10.15.36.24.13.23.7
ROCE
ROCE%
11.121.8-32.4-19.711.715.811.49.4
ROE
ROE%
9.216.3-25.7-16.39.412.79.27.3
ROA
ROA%
2.64.4-29.0-19.410.412.28.56.9
Solvency Ratios
Solvency Ratios

Documents — Star Health & Allied Insurance Company Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/rhyns7vt4kb0qx2iu1u6jt0h.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/4ola9sxb3rjonvvodbcfhz44.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/j1ohist7blivwn2qzkzp0roy.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/dhjlnek939e7wlfmndnn682p.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/c3v8p9g2cwhxqacwkstptg7d.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/s2y4mv1ag3za9i0cg8lmrtpk.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/ebrphhqsxbu6863t946unfmr.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/ntzhe88lwc8n67dllais972u.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/mbdqweeks15fh439lsbdghic.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/je9fd7hirjz27i43icohahvd.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/booift91a50b8a7it46jnz9x.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/lmop50w165b4kbl5o0kwls6t.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/zelv5cozquk273xh592zkex2.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/0g56dk0j9afzgbh0uv0o0qof.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/hlx57obcqg8fvp7cr0foienj.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/865yut3qfahyzcb726sk6cev.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/ivuaoi7sntyn52ntrsbczv91.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/jm5y7f4kvudrzbs9l9anttjn.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/ayizft02fu17ezj3vel73c4c.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/vzxi52au9hmy515ockpqyewt.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/o6g1gc61gpfwko4e5cc87ock.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/npkhc49rdok1wqq0jyc7jt81.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/vxpkiu7z8wtixdqnjzj6nrn6.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/a9azgso2581ep8s5ytjbbo4j.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/6rd2pq8r48wphniocnfvkfq6.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/vacv459g1cyi1l0ox2027nof.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/bi9n2f7kh323897v5c4rvi0q.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/1zr8kss2wu5mir4jdeiol1si.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/g61bikjl58y4q0boa66k2afi.pdf

Concall Transcript Summaries — Star Health & Allied Insurance Company Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3ASTARHEALTH/transcript-notes/202606/rhyns7vt4kb0qx2iu1u6jt0h.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3ASTARHEALTH/transcript-notes/202603/4ola9sxb3rjonvvodbcfhz44.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3ASTARHEALTH/transcript-notes/202512/j1ohist7blivwn2qzkzp0roy.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3ASTARHEALTH/transcript-notes/202509/dhjlnek939e7wlfmndnn682p.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3ASTARHEALTH/transcript-notes/202506/c3v8p9g2cwhxqacwkstptg7d.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3ASTARHEALTH/transcript-notes/202503/s2y4mv1ag3za9i0cg8lmrtpk.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3ASTARHEALTH/transcript-notes/202412/ebrphhqsxbu6863t946unfmr.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3ASTARHEALTH/transcript-notes/202409/ntzhe88lwc8n67dllais972u.pdf